These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3069492)

  • 1. [Prodrugs: goals, principles and outlook].
    Piotrovskiĭ LB; Dumpis MA
    Farmakol Toksikol; 1988; 51(6):17-25. PubMed ID: 3069492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrug strategies to overcome poor water solubility.
    Stella VJ; Nti-Addae KW
    Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps.
    Testa B
    Curr Opin Chem Biol; 2009 Jun; 13(3):338-44. PubMed ID: 19473869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of anticancer prodrugs for reductive activation.
    Chen Y; Hu L
    Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrug research: futile or fertile?
    Testa B
    Biochem Pharmacol; 2004 Dec; 68(11):2097-106. PubMed ID: 15498500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs.
    More SS; Vince R
    J Med Chem; 2008 Aug; 51(15):4581-8. PubMed ID: 18651729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy.
    Masterson LA; Spanswick VJ; Hartley JA; Begent RH; Howard PW; Thurston DE
    Bioorg Med Chem Lett; 2006 Jan; 16(2):252-6. PubMed ID: 16290933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological activity of protaxols.
    Nicolaou KC; Riemer C; Kerr MA; Rideout D; Wrasidlo W
    Nature; 1993 Jul; 364(6436):464-6. PubMed ID: 8101355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of self-immolative linkers for tumour-activated prodrug therapy.
    Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
    Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 1-(4-methanesulfonylphenyl)-5-aryl-1H-pyrazol-3-carboxylic acids: synthesis, nitric oxide release studies and anti-inflammatory activities.
    Abdellatif KR; Chowdhury MA; Dong Y; Knaus EE
    Bioorg Med Chem; 2008 Jul; 16(13):6528-34. PubMed ID: 18513975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a "true" aspirin prodrug.
    Moriarty LM; Lally MN; Carolan CG; Jones M; Clancy JM; Gilmer JF
    J Med Chem; 2008 Dec; 51(24):7991-9. PubMed ID: 19049433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorzoxazone esters of some non-steroidal anti-inflammatory (NSAI) carboxylic acids as mutual prodrugs: design, synthesis, pharmacological investigations and docking studies.
    Abdel-Azeem AZ; Abdel-Hafez AA; El-Karamany GS; Farag HH
    Bioorg Med Chem; 2009 May; 17(10):3665-70. PubMed ID: 19398345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfenamides as prodrugs of NH-acidic compounds: a new prodrug option for the amide bond.
    Guarino VR; Karunaratne V; Stella VJ
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4910-3. PubMed ID: 17604170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
    Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
    Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrugs revisited: the "ad hoc" approach as a complement to ligand design.
    Testa B; Caldwell J
    Med Res Rev; 1996 May; 16(3):233-41. PubMed ID: 8727425
    [No Abstract]   [Full Text] [Related]  

  • 20. Prodrug strategies in anticancer chemotherapy.
    Kratz F; Müller IA; Ryppa C; Warnecke A
    ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.